1.79 USD
+0.03
1.70%
At close Oct 10, 4:00 PM EDT
After hours
1.79
+0.00
0.00%
1 day
1.70%
5 days
-0.56%
1 month
-11.82%
3 months
5.92%
6 months
-24.47%
Year to date
-37.19%
1 year
-38.70%
5 years
-30.62%
 

About: Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

Employees: 987

0
Funds holding %
of 6,740 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

2,024% more call options, than puts

Call options by funds: $531K | Put options by funds: $25K

100% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 2 (+1) [Q2]

14% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 37

2% less funds holding

Funds holding: 117 [Q1] → 115 (-2) [Q2]

5.76% less ownership

Funds ownership: 62.74% [Q1] → 56.98% (-5.76%) [Q2]

11% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 19

33% less capital invested

Capital invested by funds: $154M [Q1] → $103M (-$50.8M) [Q2]

Research analyst outlook

We haven’t received any recent analyst ratings for ARAY.

Financial journalist opinion

Based on 3 articles about ARAY published over the past 30 days

Charts implemented using Lightweight Charts™